This phase II study is testing whether adding the immunotherapy drug atezolizumab to standard chemotherapy after lung cancer surgery can clear tumor DNA from the blood. The trial enrolls 100 patients with early-stage non-small cell lung cancer who had detectable tumor DNA after s…
Phase: PHASE2 • Sponsor: Nasser Hanna • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC